Stock Track | WUXI BIO Soars 5.01% in Intraday Trading on $400 Million Share Buyback Announcement

Stock Track
May 26

WUXI BIO's stock surged 5.01% during intraday trading on Tuesday, following the company's announcement of a significant share repurchase program.

The biopharmaceutical company revealed plans to buy back up to US$400 million worth of its shares in the open market. Management stated that the current market price does not reflect the company's intrinsic value or actual business prospects, viewing the substantial buyback authorization as a strong signal of confidence in its future development outlook.

The board resolution, approved on May 24, 2026, authorizes the repurchase of up to 407 million shares, representing approximately 10% of the total issued shares. The company emphasized that all buybacks will be executed in compliance with applicable regulations and market conditions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10